TRICARE Pharmacy Program RFI (Draft Section C & H)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DEFENSE HEALTH AGENCY
Contract Value
Not provided
Codes & Classification
Solicitation Number
-
NAICS
524114 - Direct Health and Medical Insurance Carriers
Classification Code
Q201
Additional Details
Documents3
The Defense Health Agency (DHA), operating under the Department of Defense, has issued a Special Notice as part of its acquisition planning for the forthcoming TRICARE Pharmacy Program (TPharm6) contract. This notice serves as a Request for Information (RFI) and is specifically aimed at soliciting industry feedback on two critical draft documents: Section C, Statement of Work, and Section H, Special Contract Requirements. The intent is to refine and enhance the program’s requirements and contractual framework prior to the formal solicitation phase.
The TPharm6 contract represents the next generation of the TRICARE Pharmacy Program, a cornerstone initiative designed to ensure comprehensive pharmacy benefits for eligible Department of Defense beneficiaries. The scope of this procurement encompasses the administration and management of pharmacy benefits, aligning with the NAICS code 524114 (Direct Health and Medical Insurance Carriers) and Product Service Code Q201, which pertains to medical services. The place of performance is within the United States.
DHA is seeking input from qualified vendors with relevant experience in large-scale health and pharmacy benefit management. The agency is particularly interested in industry perspectives on the draft Statement of Work and Special Contract Requirements, as these sections will define the program’s operational expectations, compliance obligations, and performance standards. The feedback collected will directly inform the finalization of the solicitation documents, ensuring that the contract structure is both practical and responsive to industry capabilities.
To facilitate a robust exchange of information, DHA is offering one-on-one meetings with interested vendors during the summer of 2026. These sessions are intended to provide a forum for in-depth discussion, clarification of requirements, and collaborative problem-solving. Vendors wishing to participate must submit their requests via the provided online form by May 11, 2026, at 12:00 PM Mountain Time. Additionally, all comments and questions related to the draft documents must be submitted by the same deadline to [email protected], with the subject line indicating the company name and reference to the draft documents response.
The contracting activity is managed by the Defense Health Agency, with primary contacts Viktoria Reed ([email protected], 303-676-3648) and Brooke Wolfe ([email protected], 303-676-3799) available for further inquiries. The notice, posted on September 4, 2026, remains active, and all relevant documents and instructions are accessible via the official SAM.gov opportunity page.
This RFI does not constitute a formal solicitation or a commitment to award a contract; rather, it is a critical step in market research and requirements development. There are no set-aside requirements or special considerations specified at this stage. Contractors with expertise in health insurance administration, pharmacy benefit management, and federal healthcare programs are encouraged to review the draft documents and engage with DHA to help shape the future of the TRICARE Pharmacy Program.